{"id":17,"date":"2026-08-06T08:49:01","date_gmt":"2026-08-06T08:49:01","guid":{"rendered":"https:\/\/www.peptidelab.co.il\/product\/%d7%9e%d7%95%d7%a6%d7%a8-%d7%93%d7%95%d7%92%d7%9e%d7%94-03-demo-item-c-310\/"},"modified":"2026-10-28T13:35:46","modified_gmt":"2026-10-28T13:35:46","slug":"retatrutide-40","status":"publish","type":"product","link":"https:\/\/www.peptidelab.co.il\/en\/product\/retatrutide-40\/","title":{"rendered":"Retatrutide 40mg"},"content":{"rendered":"<p><strong>Retatrutide \u2014 Retatrutide<\/strong> (also known by the spelling Retrutide, abbreviated Reta; code LY3437943) is an experimental peptide acting as a triple agonist at the GLP-1, GIP and glucagon receptors, studied in a metabolic context. This vial at 40mg concentration. Intended <strong>for laboratory research only (Research Use Only)<\/strong>.<\/p>\n<h2>What is Retatrutide?<\/h2>\n<p>Retatrutide was developed as part of the new generation of incretin and metabolic molecules, designed to act simultaneously on appetite, insulin secretion and energy balance. Its distinctive feature is that it is not a GLP-1 agonist alone but acts on three receptors in parallel.<\/p>\n<h2>Retatrutide in research<\/h2>\n<p>Retatrutide has been tested in advanced-stage clinical trials (Phase 3) in metabolic contexts, so there is more human data on it than on most research peptides \u2014 but it is still an experimental substance not approved for marketing as a drug.<\/p>\n<h3>Sources &amp; further information<\/h3>\n<p>For a full list of sources and studies, see the \"More info\" tab on this page, or browse<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Retatrutide\" target=\"_blank\" rel=\"noopener\">Retatrutide studies on PubMed<\/a>.<\/p>\n<p><em>Disclaimer: all products are intended for laboratory research only. Purchase is permitted from age 18 and up.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Reta (Retatrutide) \u2014 a triple GLP-1\/GIP\/glucagon agonist studied in the context of weight and metabolism. For research use only.<\/p>\n<p>Research reference material \u2014 an experimental peptide (LY3437943) acting as a triple agonist for the GLP-1, GIP, and glucagon receptors, studied in a metabolic context. Freeze-dried powder at 40mg concentration, high purity. For research use only.<\/p>","protected":false},"featured_media":1195,"comment_status":"open","ping_status":"closed","template":"","meta":{"_joinchat":[]},"product_brand":[],"product_cat":[26,32],"product_tag":[],"class_list":["post-17","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_cat-peptides-weight-loss","first","instock","shipping-taxable","purchasable","product-type-simple"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/product\/17","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/comments?post=17"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/media\/1195"}],"wp:attachment":[{"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/media?parent=17"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/product_brand?post=17"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/product_cat?post=17"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.peptidelab.co.il\/en\/wp-json\/wp\/v2\/product_tag?post=17"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}